Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbiopharmadive.com
BioPharma Dive - Latest News
Get the latest updates from BioPharma Dive - Latest News directly as they happen.
Follow now 143 followers
Latest posts
Last updated 1 day ago
Sanofi MS drug rejected in US gets an endorsement in Europe
1 day ago
Tolebrutinib, which the FDA recently turned back due to safety concerns, received...
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
1 day ago
Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from...
FDA approves Regeneron’s hearing loss gene therapy
2 days ago
Otarmeni, now cleared to treat a rare, inherited kind of hearing loss...
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
2 days ago
The 185-acre site will be the company’s largest single investment to date...
Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs
2 days ago
On a conference call, executives claimed that a closely watched breast cancer...
Sanofi posts upbeat sales as R&D pressure builds
2 days ago
A string of research setbacks have left the pharmaceutical giant at a...
Revolution drug shows promise in early pancreatic cancer
3 days ago
The findings build on data suggesting Revolution’s therapy could upend treatment for...
Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
3 days ago
A program that got caught up in HHS’ decision to abandon mRNA...
Merck adds to pharma’s AI push; Roche details MS drug results
3 days ago
Merck is making a $1 billion investment in a deal with Google...
An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma?
3 days ago
A new tool is giving researchers a “data center full of genius...
Tortugas debuts with $106M and brain drugs from Hansoh, Eisai
4 days ago
Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the...
Merck’s fast-ascending kidney cancer drug hits a setback
4 days ago
Welireg’s failure in first-line kidney cancer removes a blockbuster opportunity and could...